Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence.

Bone marrow is the principal site for osteoclastogenesis and osteoblastogenesis; and an increase in the former has been linked with bone loss caused by acute loss of gonadal steroids. We have now used an established murine model of accelerated senescence and osteopenia (SAMP6) to test the hypothesis that reduced osteoblastogenesis is linked with decreased bone mass. At 1 mo of age, the number of osteoblast progenitors in SAMP6 marrow was indistinguishable from controls; however a threefold decrease was found at 3-4 mo of age. Impaired osteoblast formation was temporally associated with decreased bone formation and decreased bone mineral density, as determined by histomorphometric analysis of tetracycline-labeled cancellous bone and dual-energy x-ray absorptiometry, respectively. Osteoclastogenesis determined in ex vivo bone marrow cultures was also decreased in these mice, as was the number of osteoclasts in histologic sections. Moreover, unlike controls, senescence-accelerated mice failed to increase osteoclast development after gonadectomy. The osteoclastogenesis defeat was secondary to impaired osteoblast formation as evidenced by the fact that osteoclastogenesis could be restored by addition of osteoblastic cells from normal mice. These findings provide the first demonstration of a link between low bone mineral density and decreased osteoblastogenesis in the bone marrow and validate the senescence-accelerated mouse as a model of involutional osteopenia.

[1]  H. Broxmeyer,et al.  Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. , 1995, The Journal of clinical investigation.

[2]  A. Villanueva,et al.  Relations between histologic indices of bone formation: Implications for the pathogenesis of spinal osteoporosis , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  R. Jilka,et al.  Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. , 1995, The New England journal of medicine.

[4]  K. Higuchi,et al.  Molecular genetic characterization of the senescence-accelerated mouse (SAM) strains. , 1994, Journal of gerontology.

[5]  I. Akiguchi,et al.  A novel murine model of aging, Senescence-Accelerated Mouse (SAM). , 1994, Archives of gerontology and geriatrics.

[6]  G. Passeri,et al.  Interleukin-11: a new cytokine critical for osteoclast development. , 1994, The Journal of clinical investigation.

[7]  G. Ciliberto,et al.  Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. , 1994, The EMBO journal.

[8]  B. Borremans,et al.  Characterization of a 5-fluorouracil-enriched osteoprogenitor population of the murine bone marrow. , 1993, Blood.

[9]  E. Opas,et al.  The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. , 1993, The Journal of clinical investigation.

[10]  T. A. Roy,et al.  Biochemical parameters associated with low bone density in healthy men and women , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  R. Lindsay,et al.  Maintenance of cancellous bone connectivity in primary hyperparathyroidism: Trabecular strut analysis , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  M. McKenna,et al.  Differences in vitamin D status between countries in young adults and the elderly. , 1992, The American journal of medicine.

[13]  G. Passeri,et al.  17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. , 1992, The Journal of clinical investigation.

[14]  R. Eastell,et al.  Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: Evidence of an age‐related intestinal resistance to 1,25‐dihydroxyvitamin D action , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  John A. Kanis,et al.  Bone and Mineral Research , 1991 .

[16]  F. Melsen,et al.  A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. , 1990, Bone.

[17]  R. Heaney Estrogen-calcium interactions in the postmenopause: a quantitative description. , 1990, Bone and mineral.

[18]  R. Eastell,et al.  Cancellous bone remodeling in type i (postmenopausal) osteoporosis: Quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  R. Weinstein,et al.  Diminished rates of bone formation in normal black adults. , 1988, The New England journal of medicine.

[20]  T. Martin,et al.  Osteoblastic cells are involved in osteoclast formation. , 1988, Endocrinology.

[21]  J. Gallagher,et al.  Total bone calcium in normal women: Effect of age and menopause status , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  T. Yamamuro,et al.  Age-related changes in bone mass in the senescence-accelerated mouse (SAM). SAM-R/3 and SAM-P/6 as new murine models for senile osteoporosis. , 1986, The American journal of pathology.

[24]  H. DeLuca,et al.  Bone histomorphometry in vitamin D-deficient rats infused with calcium and phosphorus. , 1984, The American journal of physiology.

[25]  C. Korzeniewski,et al.  An enzyme-release assay for natural cytotoxicity. , 1983, Journal of immunological methods.

[26]  M. Kleerekoper,et al.  Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. , 1983, The Journal of clinical investigation.

[27]  R. Lindsay,et al.  PREVENTION OF SPINAL OSTEOPOROSIS IN OOPHORECTOMISED WOMEN , 1980, The Lancet.

[28]  S. Manolagas Bone marrow, cytokines, and bone remodeling , 1995 .

[29]  M. Horowitz,et al.  Relative contributions of years since menopause, age, and weight to vertebral density in postmenopausal women. , 1992, The Journal of clinical endocrinology and metabolism.

[30]  H. Broxmeyer,et al.  Increased osteoclast development after estrogen loss: mediation by interleukin-6. , 1992, Science.

[31]  B. Hall The Osteoblast and osteocyte , 1990 .